Diffusion of the complex consisting of low density lipoprotein (LDL) bound to its receptor on the surface of human fibroblasts has been measured with the help of an intensely fluorescent, biologically ...

Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...

Studies by researchers at Washington University School of Medicine in St. Louis have found that high levels of a normal protein that is associated with reduced heart disease also protects against ...

Alzheimer's disease (AD) currently afflicts over 6 million Americans with expected financial burdens for long-term care and hospices for this population exceeding 350 billion. These numbers threaten ...

A novel once-daily oral PCSK9 inhibitor lowered LDL by up to 60% at 24 weeks in patients with heart disease or at high risk for it, according to a trial presented at the American Heart Association ...

Researchers have uncovered a long-sought link in the battle to control cholesterol and heart disease. The protein that interferes with low-density lipoprotein (LDL) receptors that clear 'bad' ...

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial ...

Pharmaceutical company Merck has created a new pill called enlicitide, which promises to lower "bad" cholesterol as ...

A groundbreaking study from the University of California, Riverside, has revealed alarming evidence that everyday exposure to microplastics the tiny particles shed from common plastics-may ...